Five entities – four companies and one executive – are now being probed by the Competition Commission of India after complaints of anticompetitive stockiest-ship appointments. Pharmaceutical companies Cipla, Macleods Pharmaceutical and FDC Ltd are all under investigation, as well as the trade body Himachal Pradesh Society of Chemist and Druggist Alliance, as well as its president. According to reports, the CCI is looking into allegations that the trade body illegally controlled the appointment of stockist-ship of the pharmaceutical companies that are part of the Society. The CCI has recognized the complaints that competitors could not be granted stockish-ship due to the collusive agreements.
Full Content: Money Life
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI